The Molecular Nature of Cholecystokinin in Plasma: An in vivo Immunosorption Study in Rabbits

References

• Rehfeld J F. Cholecystokinin. Handbook of physiology–the gastrointestinal system. II., G M. Makhlouf. American Physiological Society, Bethesda, MD 1989; 337–58
   Google Scholar
• Mutt V, Jorpes J E. Hormonal polypeptides of the upper intestine. BiochemJ 1971; 125: 57P–8P
   PubMed Web of Science ®Google Scholar
• Mutt V. Further investigations on intestinal hormonal polypeptides. Clin Endocrinol 1976; 5: 175S–83S, Suppl
   PubMedGoogle Scholar
• Dockray G J., Gregory R A., Hutchison J B., Harris J I., Runswick M. Isolation, structure and biological activity of two cholecystokinin octapeptides from sheep brain. Nature 1978; 274: 711–3
   PubMed Web of Science ®Google Scholar
• Eng Shiina J. Y., Pan Y, Blacher E., Chang R. M., Stein S, et al. Pig brain contains cholecystokinin octapeptide and several desoctapeptides. Proc Natl Acad Sci USA 1983; 80: 6381–5
   PubMed Web of Science ®Google Scholar
• Eng Du J. B., Pan Y, Chang E., Hulmes M. JD., Yalow R S. Purification and sequencing of a rat intestinal 22 amino acid C-terminal CCK-fragment. Peptides 1984; 5: 1203–6
   PubMed Web of Science ®Google Scholar
• Carlquist M, Mutt V, Jörnvall H. Characterization of two novel forms of cholecystokinin isolated from bovine intestine. Regul Peptides 1985; 11: 27–34
   PubMedGoogle Scholar
• Rehfeld J F., Hansen H F. Characterization of preprochole-cystokinin products in the porcine cerebral cortex: evidence of different processing pathways. J Biol Chem 1986; 261: 5832–40
   PubMed Web of Science ®Google Scholar
• Reeve J R., Jr, Eysseiein V, Walsh E. J., Ben-Avram H. CM, Shively J E. New molecular forms of cholecystokinin. J Biol Chem 1986; 261: 16392–7
   PubMed Web of Science ®Google Scholar
• Eberlein G, Eysseiein A. V., Davis E. MT, Lee T D., Shively J E., Grandt D, et al. Patterns of prohormone processing: order revealed by a new procholecystokinin-derived peptide. J Biol Chem 1992; 267: 1517–21
   PubMed Web of Science ®Google Scholar
• Rehfeld J F. How to measure cholecystokinin in plasma?. Gastroenterology 1984; 87: 434–8
   PubMed Web of Science ®Google Scholar
• Byrnes D J., Henderson L, Borody T, Rehfeld J F. Radioimmunoassay of cholecystokinin in human plasma. Clin Chim Acta 1981; 111: 81–9
   PubMed Web of Science ®Google Scholar
• Jansen J BMJ, Lamers C BRW. Radioimmunoassay of cholecystokinin in human tissue and plasma. Clin Chim Acta 1983; 131: 305–16
   PubMed Web of Science ®Google Scholar
• Liddle R A., Goldfine I D., Williams J A. Bioassay of cholecystokinin in rats: effects of food, trypsin inhibitor and alcohol. Gastroenterology 1984; 87: 542–9
   PubMed Web of Science ®Google Scholar
• Liddle R A., Goldfine I D., Rosen M V., Taplitz R A., Williams J A. Cholecystokinin bioactivity in human plasma. J Clin Invest 1985; 75: 1144–52
   PubMed Web of Science ®Google Scholar
• Cantor P. Evaluation of a radioimmunoassay for cholecystokinin in human plasma. Scand J Clin Lab Invest 1986; 46: 213–21
   PubMed Web of Science ®Google Scholar
• Höcker M, Schmidt W E., Creutzfeldt W, Choudhury A R., Nustede R, Schafmayer A, et al. Determination of plasma cholecystokinin (CCK) concentrations by bioassay and radioimmunoassay in man. A critical evaluation. Regul Peptides 1992; 37: 255–69
   PubMedGoogle Scholar
• Rehfeld J F., Hoist J J., Jensen S L. The molecular nature of vascularly released cholecystokinin from the isolated, perfused porcine duodenum. Regul Peptides 1982; 2: 15–28
   Google Scholar
• Maton P N., Selden A C., Chadwick V S. Large and small forms of cholecystokinin in human plasma: measurements using high pressure liquid chromatography and radioimmunoassay. Regul Peptides 1982; 4: 251–60
   PubMed Web of Science ®Google Scholar
• Walsh J H., Lamers C BHW, Valenzuela J E. Cholecystokinin-octapeptidelike immunoreactivity in human plasma. Gastroenterology 1982; 82: 538–44
   Web of Science ®Google Scholar
• Jansen J BMJ, Lamers C BHW. Molecular forms of cholecystokinin in human plasma during infusion of bombesin. Life Sci 1983; 33: 2197–205
   PubMed Web of Science ®Google Scholar
• Eysseiein V E., Boucher W, Kauffman G L., Jr, Walsh J H. Molecular heterogeneity of canine cholecystokinin in portal and peripheral plasma. Regul Peptides 1984; 9: 173–85
   PubMedGoogle Scholar
• Gaisano H Y., Reilly W, Go V LW, Olivero D, Miller L J. Large molecular forms of cholecystokinin circulating in humans. Pancreas 1986; 1: 148–53
   PubMedGoogle Scholar
• Cantor P, Rehfeld J F. The molecular nature of cholecystokinin in human plasma. Clin Chim Acta 1987; 168: 153–8
   PubMed Web of Science ®Google Scholar
• Eysseiein V E., Eberlein G A., Hesse W H., Singer M V., Goebell H, Reeve J R., Jr. Cholecystokinin-58 is the major circulating form of cholecystokinin in canine blood. J Biol Chem 1987; 262: 214–7
   PubMed Web of Science ®Google Scholar
• Eberlein G A., Eysseiein V E., Hesse W H., Goebell H, Schaefer M. Reeve JR Jr. Detection of cholecystokinin-58 in human blood by inhibition of degradation. Am J Physiol 1987; 253: G477–82
   Google Scholar
• Cantor P, Rehfeld J F. Cholecystokinin in pig plasma: release of components devoid of a bioactive COOH-terminus. Am J Physiol 1989; 256: G53–61
   PubMed Web of Science ®Google Scholar
• Fyhrquist Wallenius F. M. Improvement of antisera against polypeptide hormones. Nature 1975; 254: 82–4
   PubMed Web of Science ®Google Scholar
• Oliver L, Cano K. C. Removal of an endogenous antigen from an antibody to increase its effective affinity constant, as illustrated by thiiodothyronine assay. Clin Chem 1977; 23: 2039–45
   PubMed Web of Science ®Google Scholar
• Skrabanek Kirrane P. I., Powell D. Apparent improvement of antisera for radioimmunoassay by treatment with sodium iodide. J Immunol Methods 1977; 16: 331–8
   PubMed Web of Science ®Google Scholar
• Grønholt R, Hoist J J. Stripping of endogenous ligands from antisera against glucagon. J Immunol Methods 1983; 58: 83–90
   PubMed Web of Science ®Google Scholar
• Rehfeld J F. In vivo immunosorption–a method for examination of hormone heterogeneity at low plasma concentration: application to progastrin and its products. J Immunol Methods 1992; 153: 7–19
   PubMed Web of Science ®Google Scholar
• Gubler U, Chua A O., Hoffman B J., Collier K, Eng J. J. Cloned cDNA to cholecystokinin mRNA predicts an identical pre-procholecystokinin in pig brain and gut. Proc Natl Acad Sci USA 1984; 81: 4307–10
   PubMed Web of Science ®Google Scholar
• Deschenes R J., Lorenz L J., Haun R S., Roos B A., Collier K J., Dixon J E. Cloning and sequence analysis of a cDNA encoding rat preprocholecystokinin. Proc Natl Acad Sci USA 1984; 81: 726–30
   PubMed Web of Science ®Google Scholar
• Takahashi Y, Kato K, Hayashizaki Y, Wakabayashi T, Ohtsuka E, Matsuki S, et al. Molecular cloning of the human chole-cystokinin gene by use of a synthetic probe containing de-oxyinosine. Proc Natl Acad Sci USA 1985; 82: 1931–5
   PubMed Web of Science ®Google Scholar
• Rehfeld J F. Immunochemical studies on cholecystokinin. I. Development of sequence-specific radioimmunoassays for porcine triacontatriapeptide cholecystokinin. J Biol Chem 1978; 253: 4016–21
   PubMed Web of Science ®Google Scholar
• Rehfeld J F., Stadil F, Rubin B. Production and evaluation of antibodies for the radioimmunoassay of gastrin. Scand J Clin Lab Invest 1972; 30: 221–32
   PubMed Web of Science ®Google Scholar
• Rehfeld J F. A unique high-titer antiserum to gastrin. Scand J Clin Lab Invest 1981; 41: 723–7
   Web of Science ®Google Scholar
• Hilsted L, Rehfeld J F. Measurement of precursors for a-ami-dated hormones by radioimmunoassay of glycine-extended peptides after trypsin-carboxypeptidase B cleavage. Anal Biochem 1986; 152: 119–26
   PubMed Web of Science ®Google Scholar
• Bardram L, Rehfeld J F. Production and evaluation of monospecific antibodies for a processing-independent sequence of human progastrin. Scand J Clin Lab Invest 1989; 49: 173–81
   PubMed Web of Science ®Google Scholar
• de Magistris L, Rehfeld J F. A simple enzymatic procedure for radioimmunochemical quantitation of the large molecular forms of gastrins and cholecystokinin. Anal Biochem 1980; 102: 126–33
   PubMed Web of Science ®Google Scholar
• Ekins R, Newman B. Theoretical aspects of saturation analysis. Acta Endocrinol 1970; 11–37, Suppl 147
   Google Scholar
• Sips R. On the structure of a catalyst surface. J Chem Phys 1948; 16: 490–501
   Web of Science ®Google Scholar
• Christiansen L A., Jensen S L., Rehfeld J F., Stadil F, Christensen K C. Antral content and secretion of gastrins in pigs. Scand J Gastroenterol 1978; 13: 719–25
   PubMed Web of Science ®Google Scholar
• Calam J, Ellis J, Dockray G J. Identification and measurement of molecular variants of cholecystokinin in duodenal mucosa and plasma. J Clin Invest 1982; 69: 218–25
   PubMed Web of Science ®Google Scholar
• Jansen J BMJ, Lamers C BHW. Molecular forms of cholecystokinin in plasma from normal and gastrectomized human subjects following a fat meal. Peptides 1987; 8: 801–5
   PubMed Web of Science ®Google Scholar
• Kanayama S, Himeno S, Higashimoto Y, Yamasaki Y, Kitani T, Tarui S. Plasma cholecystokinin octapeptide-like immuno-reactivity in patients with hepatic cirrhosis. Life Sci 1987; 41: 1915–20
   PubMed Web of Science ®Google Scholar
• Sakamoto T, Fujimura M, Newman J, Zhu X G., Greeley G H., Thompson J C. Comparison of hepatic elimination of different forms of cholecystokinin in dogs. J Clin Invest 1985; 75: 280–5
   PubMed Web of Science ®Google Scholar
• Gores G J., LaRusso N F., Miller L J. Hepatic processing of cholecystokinin peptides. I. Structural specificity and mechanism of hepatic extraction. Am J Physiol 1986; 250: G344–9
   PubMed Web of Science ®Google Scholar
• Fölsh U R., Cantor P, Wilms H M., Schafmayer A, Becker H D., Creutzfeldt W. Role of cholecystokinin in the negative feedback control of pancreatic enzyme secretion in conscious rats. Gastroenterology 1987; 92: 449–58
   PubMedGoogle Scholar
• Rehfeld J F., Uvnäs-Wallensten K. Gastrins in cat and dog. J Physiol 1978; 283: 379–96
   PubMed Web of Science ®Google Scholar